{"name":"Hyun Jun Park","slug":"hyun-jun-park","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KBMSI-2","genericName":"KBMSI-2","slug":"kbmsi-2","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"KBMSI-2","genericName":"KBMSI-2","slug":"kbmsi-2","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE1tcld0T2N3MTFqVG5QMFowYWpVZHNXR0xqaWNzRFdRQlVNaGVSMm1pZnVhX1RCYXFZTWhTV0Q5Tnk0cjN4WDFTM1VIMA?oc=5","date":"2026-03-12","type":"pipeline","source":"매일경제","summary":"The second term of Hanmi Pharmaceutical CEO Park Jae-hyun, who has been at odds with Hanyang Precisi.. - 매일경제","headline":"The second term of Hanmi Pharmaceutical CEO Park Jae-hyun, who has been at odds with Hanyang Precisi.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOVGVSMUdqcnJKeEZrRzJzcjRpWUZZUFYyeWsxbXRfVTVzdWc2Z19BMzVhOVg3UmEwdzNKNUVrSWR3d0pJNG5SQXJVaE41WW9FMVVRZVk0YjRZVHhMUXpBdkpGU0hWUHZPcWlGYVNqNGVLR2lNSnpjcEVpbVlxZWxHOTJIdHFoZDZENHNNTHlDV3NWUVZkM2tiQ3RiTHpNZw?oc=5","date":"2026-03-12","type":"pipeline","source":"Seoul Economic Daily","summary":"Hanmi Pharm to Replace CEO Park Jae-hyun, Appoints Hwang Sang-yeon - Seoul Economic Daily","headline":"Hanmi Pharm to Replace CEO Park Jae-hyun, Appoints Hwang Sang-yeon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQQ2RiQWNKZFBLcEdpVVFVZG94UnBKTy05Rk1YbU9QUGRtaWwtVU5OOHRpbTVzQ3MtUTVEUGFlYm56a19hRDVhZmFCVDdJOUxncGhfVHBCOVFVMjZTMk1ZOXJjcDhuSXQyS3Z2aUU3VTNIT29QdkNPOWRfQ0N4azdRbNIBlAFBVV95cUxQY2dZQUREMVkxVEdzelhkdUNQMmtXNGdsalcyUTJyTDBPZk40bDdZSEI1WkQ1YmVsbFZpTzlkZ3pSTVBJbFh6N19jNWZueGxLSGVsbTNHa1k0N25rSFlzZENZbUd4X0o2VDlWYUIyd2xOdGlEQnBYbkUwNG9YNndLWXZicVpvN25oYlBiUnRyUm5jeVkt?oc=5","date":"2026-03-11","type":"pipeline","source":"Chosunbiz","summary":"Police clear Hanmi Pharmaceutical CEO Park Jae-hyun in embezzlement case - CHOSUNBIZ - Chosunbiz","headline":"Police clear Hanmi Pharmaceutical CEO Park Jae-hyun in embezzlement case - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPd3F6dzZ1MWJqTXphN09rbUlUdk9KdFNwNDVqZnlBVFpsRTRhaDZlX1FFcm40VE92Z21GSmRNZzhGMmFVMlNicDIzOUV3SFBSNXBvRDBfdjNUZ280MEFXZ0FjRmFla1BLcTJ5QmVVbU5NV2dmeHFiaXFlOXlkZmdqYng0ZmJvZzBRZ3J0NkF1T1paS24wdEdybTlOOUZNeU1XcEVJOW5IZ2U4V00tbk5Ia2FTdkxCeUl3aEFyckNhdHQ2b0tUejJZSDVJRW1fSDhwcU91aG4tTktfVEtSRTExWHR1ekE?oc=5","date":"2026-02-25","type":"pipeline","source":"Reuters","summary":"South Korea's birthrate, the world's lowest, rises again amid signs of easing demographic crisis - Reuters","headline":"South Korea's birthrate, the world's lowest, rises again amid signs of easing demographic crisis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOU1VGRFBYRjAtU0pXMmlsdU9yaHRXdHdBa1VCeU9fbGw4eWR1UV9lTW9MX3FMUEhob3NnU3c5QUNKd1lYSjJGV2p0Zm41TE15VFdISHRmRFZSSFVnMjJLZTJxRnVnYWFNZVBRaVZ4d1BGd1ZBTXg0OHRzM2hOSEdBdlJhZXJjLUd5dzVMd3l3?oc=5","date":"2026-02-10","type":"pipeline","source":"조선일보","summary":"Injection Aunt Threatens Exposures, Industry on Edge - 조선일보","headline":"Injection Aunt Threatens Exposures, Industry on Edge - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5LQ19kSGlQWnlFb2xNckFrUmE2M1Rvd2VLbTd6UWdRdTJYcm1Cb0g4ak5xQnVqQTdtd0hRbW0xU2hMR3dpRFJYM29HUEZqaXdHdldQWW5CdWdfdjBfUXc0b2VNdjFUMWdsblB0Zk9B0gFyQVVfeXFMTXpxVk5yV2FMR050ZUdydWJXMzFLLWxEOHdtazhHVWJBYWNSaVNJc3dKMlR6eTk3OFE4RnVFSmhLUnVjcHhSVEVMdjVhVFRESmhweU5idFNfVVAxM3RJaUNCWHM3LVZaMWZ4S0pVTHRJY2tB?oc=5","date":"2026-01-12","type":"pipeline","source":"koreabiomed.com","summary":"Hanmi Pharm and Ferring Korea agree on joint sales of nocturia treatment - koreabiomed.com","headline":"Hanmi Pharm and Ferring Korea agree on joint sales of nocturia treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9RN0tWQ2daWVdJeEJBRmdRN0dCNFpORWRuMk11RWtGcFF0SlpWS2JITVQ3VFJoR0tuaWJHRDVwNjRWSEkzUVMwNjhnUjhIUGR3emstRmcwYmlRaHfSAVdBVV95cUxORlZCdFFfdTE1dk9ZTmc2VnA2MV9JcnJaa3M4TnFFMGk3bmNLS2hiYjlaR2R3Qll0MnR2TFhfdzl0enZNYkN0aGktV1RpNU1pQnJieGJvUW8?oc=5","date":"2026-01-01","type":"pipeline","source":"aju press","summary":"Son of Mirae Asset founder moves to core Mirae unit to renew speculation on generational shift - aju press","headline":"Son of Mirae Asset founder moves to core Mirae unit to renew speculation on generational shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBXb2J3TU1LVG5jYVZXQVBEUTZBN1BDUGFpMERDT0FTNWduWWRwdFRBYzAyT0kxVVd2V3RNNkRKd2VwaWIycVBWcm80VVBqNHJUaVVxVHF5SC04VUVmOHh1cXhWcFJLN2lpaV95WDlfOXJDTHZ5dEE?oc=5","date":"2025-09-26","type":"pipeline","source":"Wiley","summary":"Needle-free, Liquid Metal-embedded Electrospray Deposition System for Controlled Microdroplet Printing - Wiley","headline":"Needle-free, Liquid Metal-embedded Electrospray Deposition System for Controlled Microdroplet Printing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9oc1k3MThRM0ZqdDFQYkVleUNQY0x3SFNabTF5T1dQNENXSENfS3N2dDQ1X1hFZkFXcThTUFpLV1l5X0ZTZjRPTUE5X1JfOTdiYUg5Q0dfZFVpUnUtcFVR?oc=5","date":"2025-03-21","type":"pipeline","source":"Nature","summary":"Diazinon induces testicular dysfunction and testicular cell damage through increased reactive oxygen species production in mouse - Nature","headline":"Diazinon induces testicular dysfunction and testicular cell damage through increased reactive oxygen species production ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1XSWNlSXk2c2JuZ1hWOFQ2WWx2bzA2OVdwanlQZTNKaGxXbXpCZXNDWGZrNTdsZjVXUFRVdlk0WUVjSDVfbmUtM1h2Z0tfR1F0bHJrNm5xajIwT21oZU9KTnlLV3ROM2JXaXVWSkN30gFyQVVfeXFMTnRLU0l4UTNyRHVxVWhSN3pBWlpHM2ZSemh1VVFrcjZNdTYwenExeWZwWlJoLVdwYlRqNWV5ejVBRFZaUGlsUnFYLWpQRXlMeF9IejdVMTF0SENjT1owOFU0RERwNzU0cEh4QXFTNlEwZm5B?oc=5","date":"2024-12-19","type":"pipeline","source":"koreabiomed.com","summary":"Hanmi Pharm CEO calls for truce after shareholder meeting blocks leadership shake-up - koreabiomed.com","headline":"Hanmi Pharm CEO calls for truce after shareholder meeting blocks leadership shake-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBmMFpKTHZNX3RudldLQkVCUHg5RmNBbHk2eUpFa1JHMHY4OFA4clBVdGRCSEljQTJkNXhMeUk0amNndUV2ZzA2eWk3eWw0aEt2bURFc1A5aUdYQUlGOEhfWm1IeTBFLWVlVnBVY0tBaGY3aGJSU19kZmVhQXg?oc=5","date":"2024-10-04","type":"pipeline","source":"The World Economic Forum","summary":"How can screening make synthetic DNA and biology safer? - The World Economic Forum","headline":"How can screening make synthetic DNA and biology safer?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1kSkFrb0k2dzJDaVlFSU9NUTJhQ3BoaUJxdXZXZWdRY3dLU0x1SFVqa2RULU9OWVBUNVRrSlZfdng0MnNfcmtSd29OOGZNOVd6Wk1fSDZwcTd5Mk51T05uTEgtUWFkWUZDNDYyN0FzdVB2M2E3OWFaLVZxbw?oc=5","date":"2018-03-01","type":"pipeline","source":"ScienceDirect.com","summary":"Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process - ScienceDirect.com","headline":"Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}